Danaher Corporation $DHR Shares Acquired by Smith Salley Wealth Management

Smith Salley Wealth Management lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 9.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,635 shares of the conglomerate’s stock after acquiring an additional 147 shares during the quarter. Smith Salley Wealth Management’s holdings in Danaher were worth $323,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Summit Global Investments grew its position in Danaher by 18.0% in the first quarter. Summit Global Investments now owns 1,057 shares of the conglomerate’s stock worth $217,000 after buying an additional 161 shares during the last quarter. Peoples Bank KS grew its position in Danaher by 6.4% in the first quarter. Peoples Bank KS now owns 1,910 shares of the conglomerate’s stock worth $392,000 after buying an additional 115 shares during the last quarter. Mechanics Bank Trust Department grew its position in Danaher by 3.0% in the first quarter. Mechanics Bank Trust Department now owns 9,507 shares of the conglomerate’s stock worth $1,949,000 after buying an additional 274 shares during the last quarter. JGP Wealth Management LLC grew its position in Danaher by 5.3% in the first quarter. JGP Wealth Management LLC now owns 3,852 shares of the conglomerate’s stock worth $790,000 after buying an additional 194 shares during the last quarter. Finally, Czech National Bank grew its position in Danaher by 5.4% in the first quarter. Czech National Bank now owns 146,962 shares of the conglomerate’s stock worth $30,127,000 after buying an additional 7,584 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Bank of America decreased their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Evercore ISI decreased their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research note on Tuesday, July 8th. Robert W. Baird lifted their target price on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Finally, Wells Fargo & Company decreased their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $245.91.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.20% of the stock is owned by company insiders.

Danaher Stock Up 1.9%

Danaher stock opened at $184.97 on Monday. The company has a market capitalization of $132.45 billion, a P/E ratio of 39.36, a P/E/G ratio of 2.63 and a beta of 0.75. The firm’s fifty day simple moving average is $199.44 and its 200-day simple moving average is $197.48. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.59.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.